Fewer 510(k) Outliers Expected With User Fees; FDA Offers Guide To MDUFMA

Device user fee implementation is not expected to have a significant near-term impact on average premarket notification review times, according to CDRH staffers, although the fees may help rein in times for "outliers," 510(k)s that take an unusually long time to review